PRESS RELEASE published on 01/31/2024 at 17:03, 2 years 1 month ago EQS-Adhoc: Vita 34 publishes preliminary figures on the course of business in 2023 Vita 34 AG publishes preliminary figures on the course of business in 2023, reporting Group revenue of EUR 76.8 million and preliminary EBITDA of EUR 4.0 million, which fell short of expectations due to extraordinary charges. The company plans to invest in cell and gene therapies and CDMO following the merger with PBKM EBITDA 2023 Vita 34 AG Preliminary Figures Cell And Gene Therapies
PRESS RELEASE published on 11/10/2023 at 14:57, 2 years 4 months ago EQS-Adhoc: Internal investigation by Vita 34 AG reveals irregularities related to a limited number of biological samples at one of its subsidiaries regarding compliance with medical law requirements
PRESS RELEASE published on 09/27/2023 at 19:21, 2 years 5 months ago EQS-Adhoc: Vita 34 AG: A subsidiary of Vita 34, FamiCordTx, will file a lawsuit against a US licensor
PRESS RELEASE published on 08/31/2023 at 10:30, 2 years 6 months ago Vita 34 stabilizes business development in the second quarter and noticeably improves earnings
PRESS RELEASE published on 05/31/2023 at 08:00, 2 years 9 months ago Vita 34 successfully implements price increases in first quarter of 2023 in generally weak market environment
PRESS RELEASE published on 05/12/2023 at 09:10, 2 years 10 months ago Vita 34 Starts Recruitment for Clinical Trial with CAR-T Drug Candidate
PRESS RELEASE published on 04/30/2023 at 12:00, 2 years 10 months ago Development of Vita 34 AG in 2022 stressed by weakened consumption power of consumers along with one-off effects
PRESS RELEASE published on 04/25/2023 at 18:43, 2 years 10 months ago EQS-Adhoc: Vita 34 AG publishes outlook for the 2023 financial year
PRESS RELEASE published on 04/06/2023 at 20:39, 2 years 11 months ago EQS-Adhoc: 2022 annual result of Vita 34 AG significantly influenced by impairment of goodwill
Published on 03/16/2026 at 22:30, 8 hours 27 minutes ago Core Silver Intersects High-Grade Copper-Molybdenum Veins up to 7.31% Cu & 1.01% Mo Confirming Large Porphyry System at Laverdiere
Published on 03/16/2026 at 22:00, 8 hours 57 minutes ago Viemed Healthcare to Present at Sidoti's Small-Cap Virtual Investor Conference March 18-19
Published on 03/16/2026 at 21:30, 9 hours 27 minutes ago Zomedica Announces Record Fourth Quarter Revenue of $10.5 Million and Full Year Revenue of $32.0 Million for 2025, Reflecting 17% Annual Growth; Achieves 68% Gross Margin and Maintains $53.3 Million in Liquidity
Published on 03/16/2026 at 21:00, 9 hours 57 minutes ago Amdocs Brings AI-Accelerated Application Modernization to Enterprises with NVIDIA
Published on 03/17/2026 at 06:29, 28 minutes ago Medartis builds on momentum with 16% organic sales growth and core EBITDA margin exceeding 18%
Published on 03/17/2026 at 03:40, 3 hours 17 minutes ago SANY and OCHA Sign Partnership Agreement at HNPW 2026
Published on 03/17/2026 at 02:10, 4 hours 47 minutes ago Clawchain.ai Launches on Chromia to Support the Next Generation of AI Agent Systems
Published on 03/17/2026 at 00:00, 6 hours 57 minutes ago Cango Inc. Reports Fourth Quarter and Full Year 2025 Unaudited Financial Results
Published on 03/16/2026 at 23:07, 7 hours 50 minutes ago KION brings physical AI into live warehouse operations at GTC 2026 in San José, California
Published on 03/16/2026 at 18:00, 12 hours 57 minutes ago Disclosure of trading in own shares from 09/03/2026 to 13/03/2026
Published on 03/16/2026 at 17:58, 12 hours 59 minutes ago Aéroports de Paris S.A - February 2026 traffic figures
Published on 03/16/2026 at 17:56, 13 hours ago Reporting on share buyback transactions carried out between March 9 and March 13, 2026
Published on 03/16/2026 at 17:35, 13 hours 22 minutes ago Disclosure of transactions in own shares from March 9 to March 13, 2026
